Skip to main content
Equibles

Caption Management, LLC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1706766 OKLAHOMA CITY, OK
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$213,000
-$2,477,722 QoQ
Shares Held
8,419
-93.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#245
of 354 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Derivatives in ACAD

reported options exposure · as of Jun 30, 2026
CallValue
$759,000
CallShares
30,000
PutValue
$3,289,000
PutShares
130,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. ACAD ranks #66 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in ACAD

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $759,000 30,000
2026-06-30 $3,289,000 130,000
2026-06-30 $213,000 8,419
2026-03-31 $4,897,200 220,000
2026-03-31 $4,006,800 180,000
2026-03-31 $2,690,722 120,877
2025-12-31 $534,200 20,000
2025-12-31 $2,671,000 100,000
2025-09-30 $13,525,292 633,800
2025-09-30 $3,762,242 176,300
2025-06-30 $647,100 30,000
2025-06-30 $182,374 8,455
2025-06-30 $647,100 30,000
2025-03-31 $1,083,370 65,224
2025-03-31 $332,200 20,000
2024-09-30 $922,800 60,000
2024-09-30 $922,800 60,000
2024-06-30 $487,500 30,000
2024-06-30 $487,500 30,000
2024-06-30 $126,750 7,800
2024-03-31 $1,231,434 66,600
2024-03-31 $3,391,066 183,400
2024-03-31 $8,546,078 462,200
2023-12-31 $782,750 25,000
2023-09-30 $2,552,900 122,500
2023-09-30 $1,510,900 72,500
2023-06-30 $658,625 27,500
2023-06-30 $658,625 27,500
2022-09-30 $736,200 45,000
2022-09-30 $736,200 45,000
2022-06-30 $3,936,746 279,400
2022-06-30 $24,882 1,766
2022-06-30 $915,850 65,000
2022-03-31 $5,367,152 221,600
2022-03-31 $455,336 18,800
2022-03-31 $2,027,214 83,700
2021-12-31 $4,924,740 211,000
2021-12-31 $2,770,458 118,700
2021-09-30 $357,115 21,500
2021-06-30 $446,337 18,300
2021-06-30 $1,390,230 57,000
2021-03-31 $6,475,800 251,000
2021-03-31 $2,881,860 111,700
2020-12-31 $4,554,792 85,200
2020-12-31 $1,603,800 30,000
2020-12-31 $3,239,676 60,600
2020-09-30 $2,277,000 55,200
2020-09-30 $1,443,750 35,000
2020-06-30 $2,445,650 50,457
2020-06-30 $2,675,544 55,200